Last Updated: May 10, 2026

List of Excipients in Branded Drug DICLOFENAC SODIUM GEL


✉ Email this page to a colleague

« Back to Dashboard


Generic Drugs Containing DICLOFENAC SODIUM GEL

Excipient Strategy and Commercial Opportunities for DICLOFENAC SODIUM GEL

Last updated: March 5, 2026

What are the key excipient considerations for diclofenac sodium gel formulation?

Diclofenac sodium gel is a topical non-steroidal anti-inflammatory drug (NSAID) used for pain and inflammation relief. The excipient selection influences stability, absorption, sensory attributes, and patient compliance.

Common excipients include:

  • Carbomer or hydroxypropyl cellulose (HPC): As gelling agents, forming the physical structure of the gel.
  • Propylene glycol: Acts as a solvent, humectant, and penetration enhancer.
  • Ethanol or isopropanol: Serve as co-solvents, aiding in drug solubilization and rapid drying.
  • Triethanolamine: Used to neutralize carbomer and adjust pH.
  • Preservatives: Such as methylparaben or propylparaben to prevent microbial growth.
  • Water: The primary solvent.

Formulation parameters: pH typically maintained between 5.5 and 7.0 for stability and skin compatibility.

How does excipient choice impact drug stability and efficacy?

Excipient effects on stability:

  • pH buffers: Maintain optimal pH to reduce hydrolysis of diclofenac.
  • Antioxidants: Ascorbic acid or other stabilizers prevent oxidative degradation.
  • Viscosity modifiers: Carbomers or HPC enhance skin adhesion and prolong contact time, increasing absorption.

Impact on efficacy:

  • Penetration enhancers: Propylene glycol increases transdermal delivery.
  • Sensory modification: Emollients and thickeners improve patient experience, encouraging adherence.

What are the key commercial opportunities driven by excipient strategies?

Differentiation through formulation innovation

  • Developing preservative-free or natural excipient-based formulations appeals to clean-label trends.
  • Enhanced absorption formulations can lower required doses and reduce side effects, adding value.

Cost optimization

  • Utilizing synthetic vs. natural excipients influences raw material costs.
  • Streamlining production with efficient gelling agents reduces manufacturing expenses.

Intellectual property extension

  • Patents covering specific excipient combinations or novel stabilizers protect market share.
  • Proprietary formulations can command premium pricing.

Market segmentation

  • Custom formulations for sensitive skin using hypoallergenic excipients target niche segments.
  • Developing waterless or reduced-water gels meets requirements for portable and convenience-focused applications.

Regulatory and supply chain considerations

  • Sourcing excipients with established safety profiles accelerates approval.
  • Ensuring supply chain stability for key excipients secures consistent product availability.

How do regulatory trends influence excipient strategies?

Regulatory agencies emphasize excipient safety and transparency. Trends include:

  • GRAS status: Preference for excipients with Generally Recognized As Safe (GRAS) designations.
  • Clean-label demands: Avoidance of certain preservatives or excipients with controversial safety profiles.
  • Global harmonization: Alignment with International Council for Harmonisation (ICH) guidelines eases approval processes.

Formulators investing in excipients with well-documented safety profiles and regulatory acceptance reduce approval timelines and mitigate compliance risks.

Summary of commercial and formulation insights

Aspect Details
Key excipients Carbomer, propylene glycol, ethanol, triethanolamine, preservatives
Innovation avenues Natural excipients, enhanced penetration, preservative-free
Cost strategies Synthetic versus natural, simplified production
Regulatory impact Preference for GRAS and well-documented excipients
Market opportunities Niche formulations, patent extensions, premium pricing

Key Takeaways

  • Excipient selection impacts stability, absorption, sensory profile, and regulatory compliance.
  • Formulation innovation focused on natural ingredients, preservative-free options, and penetration enhancement offers competitive differentiation.
  • Cost and supply chain considerations influence excipient choices and product pricing.
  • Regulatory trends favor excipients with established safety profiles, affecting strategic formulation decisions.
  • Intellectual property and patent protections hinge on unique excipient combinations and novel stabilizers.

FAQs

1. What are the most common excipients in diclofenac sodium gel?
Carbomer, propylene glycol, ethanol, triethanolamine, and preservatives like methylparaben are standard.

2. How does excipient choice affect drug absorption in topical formulations?
Penetration enhancers like propylene glycol facilitate transdermal drug delivery, increasing efficacy.

3. Can natural excipients be used in diclofenac sodium gel?
Yes. Natural gelling agents (e.g., plant-based cellulose derivatives) and plant-derived preservatives are increasingly considered for clean-label products.

4. What regulatory factors influence excipient strategies?
Safety status (GRAS), transparency, and compliance with ICH and regional guidelines impact excipient selection and formulation approval.

5. How do formulation innovations create market advantages?
Enhanced stability, improved patient compliance through sensory improvements, and patent protection extend market reach and enable premium pricing.


References

[1] European Medicines Agency. (2020). Guideline on quality of topical products. EMA.
[2] U.S. Food and Drug Administration. (2022). Inactive ingredients used in approved drug products. FDA.
[3] Singh, S., & Raju, S. (2019). Formulation strategies for topical NSAIDs. International Journal of Pharmaceutics, 565, 404–415.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.